238 related articles for article (PubMed ID: 26427514)
1. Down-regulation of IKKβ expression in glioma-infiltrating microglia/macrophages is associated with defective inflammatory/immune gene responses in glioblastoma.
Mieczkowski J; Kocyk M; Nauman P; Gabrusiewicz K; Sielska M; Przanowski P; Maleszewska M; Rajan WD; Pszczolkowska D; Tykocki T; Grajkowska W; Kotulska K; Roszkowski M; Kostkiewicz B; Kaminska B
Oncotarget; 2015 Oct; 6(32):33077-90. PubMed ID: 26427514
[TBL] [Abstract][Full Text] [Related]
2. Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma.
Close HJ; Stead LF; Nsengimana J; Reilly KA; Droop A; Wurdak H; Mathew RK; Corns R; Newton-Bishop J; Melcher AA; Short SC; Cook GP; Wilson EB
Clin Exp Immunol; 2020 Apr; 200(1):33-44. PubMed ID: 31784984
[TBL] [Abstract][Full Text] [Related]
3. The Eclectic Nature of Glioma-Infiltrating Macrophages and Microglia.
Arrieta VA; Najem H; Petrosyan E; Lee-Chang C; Chen P; Sonabend AM; Heimberger AB
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948178
[TBL] [Abstract][Full Text] [Related]
4. Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma.
Lin GL; Nagaraja S; Filbin MG; Suvà ML; Vogel H; Monje M
Acta Neuropathol Commun; 2018 Jun; 6(1):51. PubMed ID: 29954445
[TBL] [Abstract][Full Text] [Related]
5. Spatially Resolved Microglia/Macrophages in Recurrent Glioblastomas Overexpress Fatty Acid Metabolism and Phagocytic Genes.
Mistry AM; Daneshmand J; Seo SJ; Lehman NL; Miller DM; Goodin DA; Frieboes HB; Chen J; Masters A; Williams BJ; Yaddanapudi K
Curr Oncol; 2024 Feb; 31(3):1183-1194. PubMed ID: 38534921
[TBL] [Abstract][Full Text] [Related]
6. The Presence and Potential Role of ALDH1A2 in the Glioblastoma Microenvironment.
Sanders S; Herpai DM; Rodriguez A; Huang Y; Chou J; Hsu FC; Seals D; Mott R; Miller LD; Debinski W
Cells; 2021 Sep; 10(9):. PubMed ID: 34572134
[TBL] [Abstract][Full Text] [Related]
7. Blockade of CD73 delays glioblastoma growth by modulating the immune environment.
Azambuja JH; Schuh RS; Michels LR; Iser IC; Beckenkamp LR; Roliano GG; Lenz GS; Scholl JN; Sévigny J; Wink MR; Stefani MA; Battastini AMO; Figueiró F; Teixeira HF; Braganhol E
Cancer Immunol Immunother; 2020 Sep; 69(9):1801-1812. PubMed ID: 32350590
[TBL] [Abstract][Full Text] [Related]
8. Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity.
Vidyarthi A; Agnihotri T; Khan N; Singh S; Tewari MK; Radotra BD; Chatterjee D; Agrewala JN
Cancer Immunol Immunother; 2019 Dec; 68(12):1995-2004. PubMed ID: 31690954
[TBL] [Abstract][Full Text] [Related]
9. Identification of a 6-cytokine prognostic signature in patients with primary glioblastoma harboring M2 microglia/macrophage phenotype relevance.
Cai J; Zhang W; Yang P; Wang Y; Li M; Zhang C; Wang Z; Hu H; Liu Y; Li Q; Wen J; Sun B; Wang X; Jiang T; Jiang C
PLoS One; 2015; 10(5):e0126022. PubMed ID: 25978454
[TBL] [Abstract][Full Text] [Related]
10. SorLA restricts TNFα release from microglia to shape a glioma-supportive brain microenvironment.
Kaminska P; Ovesen PL; Jakiel M; Obrebski T; Schmidt V; Draminski M; Bilska AG; Bieniek M; Anink J; Paterczyk B; Jensen AMG; Piatek S; Andersen OM; Aronica E; Willnow TE; Kaminska B; Dabrowski MJ; Malik AR
EMBO Rep; 2024 May; 25(5):2278-2305. PubMed ID: 38499808
[TBL] [Abstract][Full Text] [Related]
11. Hijacking Sexual Immuno-Privilege in GBM-An Immuno-Evasion Strategy.
Sharpe MA; Baskin DS; Jenson AV; Baskin AM
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681642
[TBL] [Abstract][Full Text] [Related]
12. Glioma cancer stem cells induce immunosuppressive macrophages/microglia.
Wu A; Wei J; Kong LY; Wang Y; Priebe W; Qiao W; Sawaya R; Heimberger AB
Neuro Oncol; 2010 Nov; 12(11):1113-25. PubMed ID: 20667896
[TBL] [Abstract][Full Text] [Related]
13. PKC signaling in glioblastoma.
do Carmo A; Balça-Silva J; Matias D; Lopes MC
Cancer Biol Ther; 2013 Apr; 14(4):287-94. PubMed ID: 23358475
[TBL] [Abstract][Full Text] [Related]
14. Classification of Glioblastoma Associated with Immune Checkpoints and Tumor Microenvironment based on Immunogenomic Profiling.
Zheng P; Zhang X; Ren D; Bai Q
Neurol India; 2024 Mar; 72(2):297-303. PubMed ID: 38691473
[TBL] [Abstract][Full Text] [Related]
15. Tumor associated microglia/macrophages utilize GPNMB to promote tumor growth and alter immune cell infiltration in glioma.
Yalcin F; Haneke H; Efe IE; Kuhrt LD; Motta E; Nickl B; Flüh C; Synowitz M; Dzaye O; Bader M; Kettenmann H
Acta Neuropathol Commun; 2024 Apr; 12(1):50. PubMed ID: 38566120
[TBL] [Abstract][Full Text] [Related]
16. Effective Reprogramming of Patient-Derived M2-Polarized Glioblastoma-Associated Microglia/Macrophages by Treatment with GW2580.
Fermi V; Warta R; Wöllner A; Lotsch C; Jassowicz L; Rapp C; Knoll M; Jungwirth G; Jungk C; Dao Trong P; von Deimling A; Abdollahi A; Unterberg A; Herold-Mende C
Clin Cancer Res; 2023 Nov; 29(22):4685-4697. PubMed ID: 37682326
[TBL] [Abstract][Full Text] [Related]
17. Integrative Analysis to Identify Genes Associated with Stemness and Immune Infiltration in Glioblastoma.
Warrier NM; Agarwal P; Kumar P
Cells; 2021 Oct; 10(10):. PubMed ID: 34685742
[TBL] [Abstract][Full Text] [Related]
18. Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression.
De Boeck A; Ahn BY; D'Mello C; Lun X; Menon SV; Alshehri MM; Szulzewsky F; Shen Y; Khan L; Dang NH; Reichardt E; Goring KA; King J; Grisdale CJ; Grinshtein N; Hambardzumyan D; Reilly KM; Blough MD; Cairncross JG; Yong VW; Marra MA; Jones SJM; Kaplan DR; McCoy KD; Holland EC; Bose P; Chan JA; Robbins SM; Senger DL
Nat Commun; 2020 Oct; 11(1):4997. PubMed ID: 33020472
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam: A Potent Sword against Microglia Polarization in Gliomas.
Cui X; Wang Q; Liu X; Kang C
Clin Cancer Res; 2024 Mar; 30(6):1073-1075. PubMed ID: 38170191
[TBL] [Abstract][Full Text] [Related]
20. Immune suppression in gliomas.
Grabowski MM; Sankey EW; Ryan KJ; Chongsathidkiet P; Lorrey SJ; Wilkinson DS; Fecci PE
J Neurooncol; 2021 Jan; 151(1):3-12. PubMed ID: 32542437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
